83 related articles for article (PubMed ID: 22941379)
1. Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation.
Yanada M; Kurosawa S; Yamaguchi T; Uchida N; Miyawaki S; Kanamori H; Usuki K; Kobayashi T; Watanabe M; Nagafuji K; Yano S; Nawa Y; Tomiyama J; Tashiro H; Nakamura Y; Fujisawa S; Kimura F; Emi N; Miura I; Fukuda T
Bone Marrow Transplant; 2013 Mar; 48(3):390-5. PubMed ID: 22941379
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.
Imahashi N; Suzuki R; Fukuda T; Kakihana K; Kanamori H; Eto T; Mori T; Kobayashi N; Iwato K; Sakura T; Ikegame K; Kurokawa M; Kondo T; Iida H; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Atsuta Y; Miyamura K
Bone Marrow Transplant; 2013 Jan; 48(1):56-62. PubMed ID: 22705800
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
[TBL] [Abstract][Full Text] [Related]
4. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission.
Usuki K; Kurosawa S; Uchida N; Yakushiji K; Waki F; Matsuishi E; Kagawa K; Furukawa T; Maeda Y; Shimoyama M; Ago H; Yamano Y; Yano S; Fujishima N; Takamatsu Y; Eto T; Hidaka M; Matsuoka H; Fukuda T
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):444-51. PubMed ID: 22999942
[TBL] [Abstract][Full Text] [Related]
5. Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.
Denz U; Bertz H; Ihorst G; Wäsch R; Finke J
Bone Marrow Transplant; 2010 Aug; 45(8):1309-15. PubMed ID: 20062094
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.
Das-Gupta EP; Russell NH; Shaw BE; Pearce RM; Byrne JL
Biol Blood Marrow Transplant; 2007 Jun; 13(6):724-33. PubMed ID: 17531783
[TBL] [Abstract][Full Text] [Related]
8. Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.
Kurosawa S; Yamaguchi T; Uchida N; Miyawaki S; Usuki K; Watanabe M; Yamashita T; Kanamori H; Tomiyama J; Nawa Y; Yano S; Takeuchi J; Yakushiji K; Sano F; Uoshima N; Yano T; Nannya Y; Moriuchi Y; Miura I; Takaue Y; Fukuda T
Biol Blood Marrow Transplant; 2011 Mar; 17(3):401-11. PubMed ID: 20667478
[TBL] [Abstract][Full Text] [Related]
9. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.
Christopeit M; Kuss O; Finke J; Bacher U; Beelen DW; Bornhäuser M; Schwerdtfeger R; Bethge WA; Basara N; Gramatzki M; Tischer J; Kolb HJ; Uharek L; Meyer RG; Bunjes D; Scheid C; Martin H; Niederwieser D; Kröger N; Bertz H; Schrezenmeier H; Schmid C
J Clin Oncol; 2013 Sep; 31(26):3259-71. PubMed ID: 23918951
[TBL] [Abstract][Full Text] [Related]
10. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
11. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
12. Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
Basara N; Schulze A; Wedding U; Mohren M; Gerhardt A; Junghanss C; Peter N; Dölken G; Becker C; Heyn S; Kliem C; Lange T; Krahl R; Pönisch W; Fricke HJ; Sayer HG; Al-Ali H; Kamprad F; Niederwieser D;
Leukemia; 2009 Apr; 23(4):635-40. PubMed ID: 19151786
[TBL] [Abstract][Full Text] [Related]
13. Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.
Cho BS; Kim JH; Yoon JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
Eur J Haematol; 2013 May; 90(5):365-74. PubMed ID: 23414524
[TBL] [Abstract][Full Text] [Related]
14. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML.
Hospital MA; Thomas X; Castaigne S; Raffoux E; Pautas C; Gardin C; Bourhis JH; Reman O; de Revel T; Terré C; Preudhomme C; Fenaux P; Michallet M; Socié G; Dombret H
Bone Marrow Transplant; 2012 Nov; 47(11):1436-41. PubMed ID: 22426749
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR.
Michelis FV; Atenafu EG; Gupta V; Kim DD; Kuruvilla J; Lambie A; Lipton JH; Loach D; Messner HA
Bone Marrow Transplant; 2013 Nov; 48(11):1450-5. PubMed ID: 23686095
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
19. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.
Brunet S; Labopin M; Esteve J; Cornelissen J; Socié G; Iori AP; Verdonck LF; Volin L; Gratwohl A; Sierra J; Mohty M; Rocha V
J Clin Oncol; 2012 Mar; 30(7):735-41. PubMed ID: 22291086
[TBL] [Abstract][Full Text] [Related]
20. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
